Viewing nowBuKwang Rosuvastatin Calcium Tablet 5 mg
Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
BuKwang Pharmaceutical Co., Ltd.

MFDS item code 201501711 · Approved 2015.03.31 · Insurance code 642203690
Treatment of dyslipidemia, inhibition of atherosclerosis progression, and reduction of cardiovascular disease risk
This medication is primarily used as an adjunct for patients with primary hypercholesterolemia and mixed hyperlipidemia when dietary measures and exercise are insufficient. It also assists patients with homozygous familial hypercholesterolemia alongside dietary changes or other lipid-lowering therapies. This drug lowers total cholesterol and LDL cholesterol levels, delaying the progression of atherosclerosis, and is also beneficial for treating patients with dysbetalipoproteinemia. It is effective in reducing the risk of cardiovascular diseases, especially in middle-aged patients with high levels of high-sensitivity C-reactive protein and additional risk factors, helping to reduce the risk of stroke, myocardial infarction, and arterial revascularization procedures. Therefore, this medication is used for hyperlipidemia and reducing the risk of cardiovascular diseases.
1. Primary hypercholesterolemia (type IIa, excluding heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine, and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily; if a greater reduction in LDL cholesterol is needed, the dose may be adjusted to a maintenance dose. The maintenance dose is 10 milligrams once daily, which is sufficient for most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer based on LDL cholesterol levels, treatment goals, and patient response, and may be increased to a maximum of 20 milligrams daily. 2. Elderly patients: No dosage adjustment is necessary. 3. Patients with renal impairment: No dosage adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Exercise particular caution when administering 20mg of this medicine to patients with moderate renal impairment. 4. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 5. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 6. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose of this medicine is contraindicated in some of these patients.
This medication should not be administered to certain patients. For example, individuals who are allergic to any component of this medication, those with active liver disease, patients with muscle disorders, individuals with severe renal impairment, and women who are pregnant or breastfeeding should not take this medication. Furthermore, those susceptible to muscle disorders should avoid high doses, and patients with genetic issues such as lactose intolerance should not use this drug. Regular liver function tests are necessary before and during treatment with this medication, and individuals who consume alcohol heavily or have a history of liver disease should exercise caution. If symptoms such as myalgia, muscle weakness, or myopathy occur, the physician should be notified immediately, and in severe cases, the medication should be discontinued. Patients at risk of severe muscle weakness or rhabdomyolysis should exercise particular caution, and the risk of muscle-related side effects may increase with concomitant medications. This medication interacts with certain drugs, increasing blood concentrations, so it must be discussed with a physician when used in combination with other medications. Women who are pregnant or breastfeeding should not take this medication, and women of childbearing potential should use appropriate contraception. There is no specific antidote for overdose; treatment should be based on symptoms, and liver function and muscle enzyme levels should be carefully monitored. Additionally, dizziness may occur during treatment, so caution is needed when driving or operating machinery. This drug may show higher blood concentrations in Asians; thus, dosage adjustments may be necessary. Lastly, rare, severe adverse events like skin rashes, liver function abnormalities, and nervous system disorders can occur while taking this medication, so immediate consultation with healthcare professionals is required if any abnormal symptoms appear.
Hypersensitivity reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, urticaria, myalgia, myopathy, rhabdomyolysis, asthenia, polyneuropathy, amnesia, peripheral neuropathy, severe muscle weakness, cough, dyspnea, diarrhea, oculobulbar weakness, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms, lichenoid drug eruption, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal hepatic failure, cognitive impairment, elevated ALT, chest pain, muscle cramps, gout, erectile dysfunction, numbness, paresthesia, chest discomfort, anorexia, abdominal distension, syncope, generalized pain, fatigue
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from exposure to air or moisture. It is important to maintain storage temperatures between 1 and 30 degrees Celsius at room temperature to ensure the longevity of the drug's effectiveness.
Yellow round film-coated tablet
28 tablets (14 tablets/PTP×2)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRosuvastatin Calcium 5.2mg
Tablet · Prescription medication
BuKwang Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Dong Gu Bio Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.